YOLO - AdvisorShares Pure Cannabis ETF
| Previous Close | 8.23 |
| Open | 7.76 |
| Bid | 8.12 x 1300 |
| Ask | 8.19 x 1800 |
| Day's Range | 8.02 - 8.23 |
| 52 Week Range | 5.65 - 26.50 |
| Volume | 48,871 |
| Avg. Volume | 66,979 |
| Net Assets | 40.4M |
| NAV | 7.13 |
| PE Ratio (TTM) | N/A |
| Yield | N/A |
| YTD Daily Total Return | -40.51% |
| Beta (5Y Monthly) | N/A |
| Expense Ratio (net) | 0.74% |
| Inception Date | 2019-04-17 |
- Benzinga
Willie Nelson Is The Hero That The Cannabis Industry Needs
When acclaimed country musician Willie Nelson achieved commercial success in the 1970s, he was already in his late thirties. Willie had been making music for over 30 years without any significant hits, and by 1970 his career was at a downfall.
- Benzinga
Benzinga Cannabis Managing Director Javier Hasse To Speak At CanEx Investment Summit In NY, Feb 18
Benzinga Cannabis Managing Director Javier Hasse is going on a speaking tour once again in 2020, with confirmed spots at big events including SXSW in Austin, Texas; the Benzinga Cannabis Capital Conference ...
- Zacks
Cannabis ETFs Are Soaring in 2020: Will the Trend Continue?
With a greater legislative push to legalize recreational marijuana, cannabis ETFs are soaring to start the year and are likely to continue doing so.
- Yahoo Finance
AdvisorShares CEO says 2020 'could be a good year' for cannabis
Despite waning investor optimism in the cannabis space, AdvisorShares CEO Noah Hamman says 2020 could be a big year for the sector.
- Benzinga
NatGeo's Jason Silva On Cannabis, Psychology And 'The Psychedelic Renaissance'
Jason Silva is a TV personality, filmmaker, speaker and futurist. Silva comes from a culturally driven household in Venezuela, where he lived until he moved to the U.S. at 18. As a teenager, Silva says he became aware that the environment in which cannabis is consumed is as important as the quality of the plant itself.
- Zacks
What's Ahead for Marijuana ETFs After a Dismal Show in 2019?
Marijuana ETFs hit a high in 2018 only to experience a bloodbath in 2019. Let's see what lies in store for the space in 2020.
- Benzinga
Data: Cannabis M&A And Raises Tanking Hard As 2020 Approaches
The Viridian Cannabis Deal Tracker is an information service that monitors capital raise and M&A activity in the legal cannabis industry. Analyzing within 12 key industry sectors, the Viridian Cannabis Deal Tracker provides cannabis companies, investors, and acquirers with the data, trends, and intelligence they need to make informed decisions regarding deal valuations, terms, and structures. Since its inception, the Viridian Cannabis Deal Tracker has tracked and analyzed more than 2,400 capital raises totaling over $29 billion as well as more than 900 M&A transactions.
- Benzinga
Here's How To Showcase Your Cannabis Company At SXSW – For Free!
Among the many hot cannabis panels and events we’ll see at SXSW 2020, there’s one offering you an opportunity to showcase your cannabis company for free: Cannabis Jumpstart: A Business Showcase, hosted by CanopyBoulder. The event will consist of six cannabis, hemp or CBD companies presenting their businesses live, on stage, in front of a panel of cannabis experts and venture capitalists. The best presentation as determined by the judges will be announced at the end of the session and the winner will receive a free pass to SXSW 2021, along with a basket of other prizes.
- Benzinga
Viridian Cannabis Deal Tracker: Investment And M&A Remain Very Low, Compared To 2018
The Viridian Cannabis Deal Tracker is an information service that monitors capital raise and M&A activity in the legal cannabis industry. Analyzing within 12 key industry sectors, the Viridian Cannabis Deal Tracker provides cannabis companies, investors, and acquirers with the data, trends, and intelligence they need to make informed decisions regarding deal valuations, terms, and structures. Since its inception, the Viridian Cannabis Deal Tracker has tracked and analyzed more than 2,400 capital raises totaling over $29 billion as well as more than 900 M&A transactions.
- Benzinga
Exclusive: WAYV, Hypur Partner To Launch Digital, 'Credit Card-Like' Finance Solution For Cannabis Industry
WAYV, the VC-backed company launched by Eaze’s founder Keith McCarty, and finance and compliance tech company Hypur have partnered up to launch a “credit card-like” B2B technology solution for the cannabis industry. The payments solution, aimed at the entire cannabis supply chain, helps businesses reduce their reliance on cash, move money across the supply chain digitally, and automate compliance and taxes. McCarty told Benzinga WAYV was founded to solve one the biggest problems the legal cannabis industry faces today: finances.
- Benzinga
Uruguay Senate Approves New Bill To Regulate Access To Medical Cannabis
To help put a definitive end to persisting illicit cannabis markets, Uruguay's senate has passed a new bill to regulate medical marijuana. The bill, "A Comprehensive Law for the Promotion and Access to Medical and Therapeutic Cannabis," was introduced into Congress by the "Ir" sector of the “Frente Amplio” party, and approved unanimously. The new bill also presents guidelines for pharmaceutical compounding.
- Benzinga
Podcast: Hip Hop And The Politics Of Weed With Benzinga's Javier Hasse And Digital Underground's 'Vegas Don'
This week on the show, we dive into hot topic in the world of Hip Hop and Politics. Javier Hasse is the author of the book Start Your Own Cannabis Business (Entrepreneur Press 2018), which hit the #1 Best Seller spot on Amazon, as well as a cannabis-focused, award-winning reporter and editor, with more than 4,700 unique articles published across numerous mass media outlets.
- Benzinga
Brazil Regulates Sale Of Medical Marijuana Products
Brazil has become the third Latin American country to regulate the sale of medical marijuana after Uruguay and Colombia. On Tuesday, ANVISA (the National Agency for Health Supervision) announced it has unanimously approved the regulation of medical marijuana to be sold at pharmacies and drugstores nationwide. Brazil is Latin America’s biggest and most-populated country, with over 210 million inhabitants.
- Zacks
Cannabis ETFs in Focus on Thanksgiving Weekend
Cannabis spending rises over the Thanksgiving holiday period, especially Green Wednesday as well as on Black Friday.
- Zacks
Marijuana ETFs Bounce Back: Can the Rally Last?
Passing of a legalization bill by a U.S. congressional committee boosted the battered marijuana ETF space lately.
- ETF Database
Best & Worst Monthly Performers: November 21 Edition
Here is a look at the 25 best and 25 worst ETFs from the past trading month. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as potential starting points for those looking to take on either short or long positions. Likewise, traders can also use this list to spot potential trend reversal opportunities that may offer a generous risk/reward. As always, investors of all experience levels are advised to use stop-loss orders and practice disciplined profit-taking techniques. To get access to all ETFdb.com premium content, sign up for a free 14-day trial to ETFdb.com Pro.
- Zacks
Can Bill Hopes Relieve Earnings-Induced Pain in Pot ETFs?
A wave of disappointing earnings caused a bloodbath in marijuana ETFs last week. However, talks of an end to the federal embargo on marijuana could turn this segment around.
CNW GroupSundial Added to the NYSE-Listed The AdvisorShares Pure Cannabis ETF
Sundial Added to the NYSE-Listed The AdvisorShares Pure Cannabis ETF
- Benzinga
Tax Considerations For Cannabis Business And Investment
The growing cannabis industry has piqued the interest of many business owners and investors who predict it could become a multi-billion dollar industry. Legal developments bolster this enthusiasm, as more than 30 states and the District of Columbia have thus far legalized marijuana for medical and/or recreational purposes.
- Zacks
Top ETF Stories of October
Announcement of phase-one trade deal, Fed rate cut, moderate earnings, marijuana crash and Brexit extension regulated the ETF world in October.
- Zacks
Should You Buy the Dip in Marijuana ETFs Ahead of Earnings?
Hexo's downbeat results weigh on marijuana space but many key pot companies are likely to beat in November. This could provide a good entry points to pot ETFs.
- Zacks
Top and Flop ETFs of October
Signs of some progress in the U.S.-China trade relation, Brexit doldrums, oil price rally and mixed earnings pulled the stings of the market movement and made these ETFs winners and losers.
- Benzinga
Canada Sold $1.1B Of Legal Cannabis In First Year; Black Market Still Dominates
Thursday marked the one-year anniversary of the legalization of recreational marijuana in Canada. Legally accredited cannabis producers in Canada sold about $1.1 billion of legal weed during the first year of legalization, according to an analysis of retail sales data by Cannabis Benchmarks.
- Yahoo Finance
Pot stocks ‘significantly oversold’: ETF manager
Legal pot could provide "significant upside" for investors, ETF manager says
